{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:06:11Z","timestamp":1790867171221,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gender differences among patients with drug resistant tuberculosis (DRTB) and HIV co-infection could affect treatment outcomes. We compared characteristics and treatment outcomes of DRTB\/HIV co-infected men and women in Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective chart review of patients with DRTB from 16 treatment sites in Uganda. Eligible patients were aged\u2009\u2265\u200918\u00a0years, had confirmed DRTB, HIV co-infection and a treatment outcome registered between 2013 and 2019. We compared socio-demographic and clinical characteristics and tuberculosis treatment outcomes between men and women. Potential predictors of mortality were determined by cox proportional hazard regression analysis that controlled for gender. Statistical significance was set at p\u2009&lt;\u20090.05.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 666 DRTB\/HIV co-infected patients, 401 (60.2%) were men. The median (IQR) age of men and women was 37.0 (13.0) and 34.0 (13.0) years respectively (p\u2009&lt;\u20090.001). Men were significantly more likely to be on tenofovir-based antiretroviral therapy (ART), high-dose isoniazid-containing DRTB regimen and to have history of cigarette or alcohol use. They were also more likely to have multi-drug resistant TB, isoniazid and streptomycin resistance and had higher creatinine, aspartate and gamma-glutamyl aminotransferase and total bilirubin levels. Conversely, women were more likely to be unemployed, unmarried, receive treatment from the national referral hospital and to have anemia, a capreomycin-containing DRTB regimen and zidovudine-based ART. Treatment success was observed among 437 (65.6%) and did not differ between the genders. However, mortality was higher among men than women (25.7% vs. 18.5%, p\u2009=\u20090.030) and men had a shorter mean (standard error) survival time (16.8 (0.42) vs. 19.0 (0.46) months), Log Rank test (p\u2009=\u20090.046). Predictors of mortality, after adjusting for gender, were cigarette smoking (aHR\u2009=\u20094.87, 95% CI 1.28\u201318.58, p\u2009=\u20090.020), an increase in alanine aminotransferase levels (aHR\u2009=\u20091.05, 95% CI 1.02\u20131.07, p\u2009&lt;\u20090.001), and history of ART default (aHR\u2009=\u20093.86, 95% CI 1.31\u201311.37, p\u2009=\u20090.014) while a higher baseline CD4 count was associated with lower mortality (aHR\u2009=\u20090.94, 95% CI 0.89\u20130.99, p\u2009=\u20090.013 for every 10\u00a0cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      increment).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Mortality was higher among men than women with DRTB\/HIV co-infection which could be explained by several sociodemographic and clinical differences.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-06801-5","type":"journal-article","created":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T01:02:18Z","timestamp":1635037338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Joseph Baruch","family":"Baluku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mukasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bongomin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stadelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Nuwagira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kauthrah","family":"Ntabadde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavia","family":"Turyahabwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,24]]},"reference":[{"key":"6801_CR1","volume-title":"Global tuberculosis report","author":"World Health Organisation","year":"2020","unstructured":"World Health Organisation. Global tuberculosis report. Geneva: World Health Organisation; 2020."},{"issue":"12","key":"6801_CR2","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S1473-3099(18)30625-X","volume":"18","author":"HH Kyu","year":"2018","unstructured":"Kyu HH, Maddison ER, Henry NJ, Ledesma JR, Wiens KE, Reiner R, et al. Global, regional, and national burden of tuberculosis, 1990\u20132016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet Infect Dis. 2018;18(12):1329\u201349.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"6801_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2471\/BLT.18.228577","volume":"97","author":"C Dye","year":"2019","unstructured":"Dye C, Williams BG. Tuberculosis decline in populations affected by HIV: a retrospective study of 12 countries in the WHO African Region. Bull World Health Organ. 2019;97(6):405\u201314.","journal-title":"Bull World Health Organ"},{"issue":"8","key":"6801_CR4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.5588\/ijtld.15.0123","volume":"19","author":"P Isaakidis","year":"2015","unstructured":"Isaakidis P, Casas EC, Das M, Tseretopoulou X, Ntzani EE, Ford N. Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2015;19(8):969\u201378.","journal-title":"Int J Tuberc Lung Dis"},{"key":"6801_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874613601610010034","volume":"10","author":"ABM Kharsany","year":"2016","unstructured":"Kharsany ABM, Karim QA. HIV infection and AIDS in Sub-Saharan Africa: current status. Chall Oppor Open AIDS J. 2016;10:34\u201348.","journal-title":"Chall Oppor Open AIDS J"},{"issue":"1","key":"6801_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1186\/s12879-019-4317-4","volume":"19","author":"ED Chem","year":"2019","unstructured":"Chem ED, Van Hout MC, Hope V. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):723.","journal-title":"BMC Infect Dis"},{"issue":"suppl_3","key":"6801_CR7","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1093\/infdis\/jiu147","volume":"209","author":"S Nhamoyebonde","year":"2014","unstructured":"Nhamoyebonde S, Leslie A. Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis. 2014;209(suppl_3):S100\u20136.","journal-title":"J Infect Dis"},{"issue":"5","key":"6801_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/heapol\/czm026","volume":"22","author":"F Karim","year":"2007","unstructured":"Karim F, Islam MA, Chowdhury AMR, Johansson E, Diwan VK. Gender differences in delays in diagnosis and treatment of tuberculosis. Health Policy Plan. 2007;22(5):329\u201334.","journal-title":"Health Policy Plan"},{"issue":"1","key":"6801_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3346\/jkms.2011.26.1.33","volume":"26","author":"DS Jeon","year":"2011","unstructured":"Jeon DS, Shin DO, Park SK, Seo JE, Seo HS, Cho YS, et al. Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector. J Korean Med Sci. 2011;26(1):33\u201341.","journal-title":"J Korean Med Sci"},{"issue":"3","key":"6801_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5588\/pha.14.0029","volume":"4","author":"E Elliott","year":"2014","unstructured":"Elliott E, Draper HR, Baitsiwe P, Claassens MM. Factors affecting treatment outcomes in drug-resistant tuberculosis cases in the Northern Cape, South Africa. Public Health Action. 2014;4(3):201\u20133.","journal-title":"Public Health Action"},{"issue":"Suppl 2","key":"6801_CR11","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.5588\/pha.14.0048","volume":"4","author":"G Kuchukhidze","year":"2014","unstructured":"Kuchukhidze G, Kumar AMV, de Colombani P, Khogali M, Nanava U, Blumberg HM, et al. Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia. Public Health Action. 2014;4(Suppl 2):S41-46.","journal-title":"Public Health Action"},{"key":"6801_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijid.2019.02.010","volume":"81","author":"M Yunusbaeva","year":"2019","unstructured":"Yunusbaeva M, Borodina L, Alekseev P, Davydov R, Yunusbaev U, Sharipov R, et al. Treatment efficacy of drug-resistant tuberculosis in Bashkortostan, Russia: a retrospective cohort study. Int J Infect Dis. 2019;81:203\u20139.","journal-title":"Int J Infect Dis"},{"key":"6801_CR13","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell MR, Zelnick J, Werner L, Master I, Loveday M, Horsburgh CR, et al. Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa. Emerg Infect Dis J. 2011;17(10). https:\/\/wwwnc.cdc.gov\/eid\/article\/17\/10\/11-0105_article.","DOI":"10.3201\/eid1710.110105"},{"issue":"1","key":"6801_CR14","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1186\/s12889-016-3783-5","volume":"16","author":"D Sia","year":"2016","unstructured":"Sia D, Onadja Y, Hajizadeh M, Heymann SJ, Brewer TF, Nandi A. What explains gender inequalities in HIV\/AIDS prevalence in sub-Saharan Africa? Evidence from the demographic and health surveys. BMC Public Health. 2016;16(1):1136.","journal-title":"BMC Public Health"},{"issue":"2","key":"6801_CR15","doi-asserted-by":"publisher","first-page":"e0148502","DOI":"10.1371\/journal.pone.0148502","volume":"11","author":"HK Hegdahl","year":"2016","unstructured":"Hegdahl HK, Fylkesnes KM, Sand\u00f8y IF. Sex differences in HIV prevalence persist over time: evidence from 18 countries in Sub-Saharan Africa. PLoS ONE. 2016;11(2):e0148502.","journal-title":"PLoS ONE"},{"issue":"1","key":"6801_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12981-015-0076-5","volume":"12","author":"DJ Pepper","year":"2015","unstructured":"Pepper DJ, Schomaker M, Wilkinson RJ, de Azevedo V, Maartens G. Independent predictors of tuberculosis mortality in a high HIV prevalence setting: a retrospective cohort study. AIDS Res Ther. 2015;12(1):35.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"6801_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12889-016-3972-2","volume":"17","author":"JC Heunis","year":"2017","unstructured":"Heunis JC, Kigozi NG, Chikobvu P, Botha S, van Rensburg HD. Risk factors for mortality in TB patients: a 10-year electronic record review in a South African province. BMC Public Health. 2017;17(1):38.","journal-title":"BMC Public Health"},{"issue":"1","key":"6801_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12879-019-4014-3","volume":"19","author":"D Okethwangu","year":"2019","unstructured":"Okethwangu D, Birungi D, Biribawa C, Kwesiga B, Turyahabwe S, Ario AR, et al. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013\u20132017. BMC Infect Dis. 2019;19(1):387.","journal-title":"BMC Infect Dis"},{"key":"6801_CR19","doi-asserted-by":"publisher","first-page":"e2508283","DOI":"10.1155\/2020\/2508283","volume":"2020","author":"JB Baluku","year":"2020","unstructured":"Baluku JB, Mugabe P, Mulwana R, Nassozi S, Katuramu R, Worodria W. High prevalence of rifampicin resistance associated with rural residence and very low bacillary load among TB\/HIV-coinfected patients at the national tuberculosis treatment center in Uganda. BioMed Res Int. 2020;2020:e2508283.","journal-title":"BioMed Res Int"},{"key":"6801_CR20","first-page":"100221","volume":"23","author":"JB Baluku","year":"2021","unstructured":"Baluku JB, Nakazibwe B, Naloka J, Nabwana M, Mwanja S, Mulwana R, et al. Treatment outcomes of drug resistant tuberculosis patients with multiple poor prognostic indicators in Uganda: a countrywide 5-year retrospective study. J Clin Tuberc Mycobact Dis. 2021;23:100221.","journal-title":"J Clin Tuberc Mycobact Dis"},{"issue":"12","key":"6801_CR21","doi-asserted-by":"publisher","first-page":"e0244451","DOI":"10.1371\/journal.pone.0244451","volume":"15","author":"S Kasozi","year":"2020","unstructured":"Kasozi S, Kirirabwa NS, Kimuli D, Luwaga H, Kizito E, Turyahabwe S, et al. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda. PLoS ONE. 2020;15(12):e0244451.","journal-title":"PLoS ONE"},{"key":"6801_CR22","volume-title":"Uganda national guidelines for the programmatic management of drug resistant tuberculosis","author":"Ministry of Health","year":"2011","unstructured":"Ministry of Health. Uganda national guidelines for the programmatic management of drug resistant tuberculosis. Kampala: Ministry of Health; 2011."},{"key":"6801_CR23","volume-title":"Uganda national guidelines for the programmatic management of drug resistant tuberculosis","author":"Ministry of Health","year":"2016","unstructured":"Ministry of Health. Uganda national guidelines for the programmatic management of drug resistant tuberculosis. 2nd ed. Kampala: Ministry of Health; 2016.","edition":"2"},{"key":"6801_CR24","unstructured":"Ministry of Health. Short treatment regimen (STR) for MDR-TB: Annex 9. In: Uganda national guidelines for the programmatic management of drug resistant tuberculosis. 2017."},{"issue":"1","key":"6801_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-021-01597-1","volume":"21","author":"JB Baluku","year":"2021","unstructured":"Baluku JB, Katuramu R, Naloka J, Kizito E, Nabwana M, Bongomin F. Multidisciplinary management of difficult-to-treat drug resistant tuberculosis: a review of cases presented to the national consilium in Uganda. BMC Pulm Med. 2021;21(1):1\u20138.","journal-title":"BMC Pulm Med"},{"key":"6801_CR26","volume-title":"Consolidated guidelines for prevention and treatment of HIV in Uganda","author":"Ministry of Health","year":"2016","unstructured":"Ministry of Health. Consolidated guidelines for prevention and treatment of HIV in Uganda. Kampala: Ministry of Health; 2016."},{"key":"6801_CR27","unstructured":"World Health Organization. Definitions and reporting framework for tuberculosis\u20132013 revision. World Health Organization; 2013. Report No.: 9241505346."},{"issue":"9","key":"6801_CR28","doi-asserted-by":"publisher","first-page":"e1002119","DOI":"10.1371\/journal.pmed.1002119","volume":"13","author":"KC Horton","year":"2016","unstructured":"Horton KC, MacPherson P, Houben RMGJ, White RG, Corbett EL. Sex differences in tuberculosis burden and notifications in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2016;13(9):e1002119.","journal-title":"PLoS Med"},{"key":"6801_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2147\/IDR.S164596","volume":"11","author":"M-G Wang","year":"2018","unstructured":"Wang M-G, Huang W-W, Wang Y, Zhang Y-X, Zhang M-M, Wu S-Q, et al. Association between tobacco smoking and drug-resistant tuberculosis. Infect Drug Resist. 2018;11:873\u201387.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"6801_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/1471-2334-14-409","volume":"14","author":"NM Zetola","year":"2014","unstructured":"Zetola NM, Macesic N, Modongo C, Shin S, Ncube R, Collman RG. Longer hospital stay is associated with higher rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan Africa. BMC Infect Dis. 2014;14(1):409.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"6801_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pulmoe.2018.03.004","volume":"24","author":"R Mar\u00e7\u00f4a","year":"2018","unstructured":"Mar\u00e7\u00f4a R, Ribeiro AI, Z\u00e3o I, Duarte R. Tuberculosis and gender\u2014factors influencing the risk of tuberculosis among men and women by age group. Pulmonology. 2018;24(3):199\u2013202.","journal-title":"Pulmonology"},{"issue":"3","key":"6801_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/1753-6405.12619","volume":"41","author":"PH Mason","year":"2017","unstructured":"Mason PH, Snow K, Asugeni R, Massey PD, Viney K. Tuberculosis and gender in the Asia-Pacific region. Aust N Z J Public Health. 2017;41(3):227\u20139.","journal-title":"Aust N Z J Public Health"},{"key":"6801_CR33","unstructured":"Ministry of Health. Uganda population-based HIV impact assessment (UPHIA) 2016\u20132017. Kampala: Ministry of Health; 2019. http:\/\/uac.go.ug\/sites\/default\/files\/UPHIA%20Final%20Report%20%5B2016%20-%202017%5D.pdf."},{"key":"6801_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40249-015-0045-1","volume":"4","author":"W-B Li","year":"2015","unstructured":"Li W-B, Zhang Y-Q, Xing J, Ma Z-Y, Qu Y-H, Li X-X. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China. Infect Dis Poverty. 2015;4:14.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"6801_CR35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12879-019-3931-5","volume":"19","author":"M El Hamdouni","year":"2019","unstructured":"El Hamdouni M, Bourkadi JE, Benamor J, Hassar M, Cherrah Y, Ahid S. Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study. BMC Infect Dis. 2019;19(1):316.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"6801_CR36","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1513\/AnnalsATS.201312-447OC","volume":"11","author":"K Duraisamy","year":"2014","unstructured":"Duraisamy K, Mrithyunjayan S, Ghosh S, Nair SA, Balakrishnan S, Subramoniapillai J, et al. Does alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome? Ann Am Thorac Soc. 2014;11(5):712\u20138.","journal-title":"Ann Am Thorac Soc"},{"key":"6801_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13756-019-0561-z","volume":"8","author":"IS Pradipta","year":"2019","unstructured":"Pradipta IS, van\u2019t Boveneind-Vrubleuskaya N, Akkerman OW, Alffenaar JC, Hak E. Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005\u20132015. Antimicrob Resist Infect Control. 2019;8:115.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"6801_CR38","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s12879-017-2746-5","volume":"17","author":"M Atif","year":"2017","unstructured":"Atif M, Bashir A, Ahmad N, Fatima RK, Saba S, Scahill S. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients. BMC Infect Dis. 2017;17(1):655.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"6801_CR39","doi-asserted-by":"publisher","first-page":"596","DOI":"10.5588\/ijtld.11.0591","volume":"16","author":"S Keshavjee","year":"2012","unstructured":"Keshavjee S, Gelmanova I, Shin S, Mishustin S, Andreev Y, Atwood S, et al. Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome. Int J Tuberc Lung Dis. 2012;16(5):596\u2013603.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"6801_CR40","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/14787210.2019.1689818","volume":"17","author":"MH Ali","year":"2019","unstructured":"Ali MH, Alrasheedy AA, Kibuule D, Godman B, Hassali MA, Ali HMH. Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications. Expert Rev Anti Infect Ther. 2019;17(11):927\u201337.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"6801_CR41","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1183\/09031936.00155708","volume":"33","author":"K Kliiman","year":"2009","unstructured":"Kliiman K, Altraja A. Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB. Eur Respir J. 2009;33(5):1085\u201394.","journal-title":"Eur Respir J"},{"issue":"1","key":"6801_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-2334-10-156","volume":"10","author":"C-P Wen","year":"2010","unstructured":"Wen C-P, Chan T-C, Chan H-T, Tsai M-K, Cheng T-Y, Tsai S-P. The reduction of tuberculosis risks by smoking cessation. BMC Infect Dis. 2010;10(1):156.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"6801_CR43","doi-asserted-by":"publisher","first-page":"947","DOI":"10.5588\/ijtld.16.0693","volume":"21","author":"B Thomas","year":"2017","unstructured":"Thomas B, Watson B, Senthil E, Deepalakshmi A, Balaji G, Chandra S, et al. Alcohol intervention strategy among tuberculosis patients: a pilot study from South India. Int J Tuberc Lung Dis. 2017;21(8):947\u201352.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"17","key":"6801_CR44","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1097\/01.aids.0000194130.05264.83","volume":"19","author":"E Kinai","year":"2005","unstructured":"Kinai E, Hanabusa H. Renal tubular toxicity associated with tenofovir assessed using urine-beta 2 microglobulin, percentage of tubular reabsorption of phosphate and alkaline phosphatase levels. AIDS Lond Engl. 2005;19(17):2031\u20133.","journal-title":"AIDS Lond Engl"},{"issue":"5","key":"6801_CR45","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/QAI.0000000000001705","volume":"78","author":"R Perumal","year":"2018","unstructured":"Perumal R, Abdelghani N, Naidu N, Yende-Zuma N, Dawood H, Naidoo K, et al. Risk of nephrotoxicity in patients with drug-resistant tuberculosis treated with kanamycin\/capreomycin with or without concomitant use of tenofovir-containing antiretroviral therapy. J Acquir Immune Defic Syndr 1999. 2018;78(5):536\u201342.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"3","key":"6801_CR46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"EG Giannini","year":"2005","unstructured":"Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ Can Med Assoc J. 2005;172(3):367\u201379.","journal-title":"CMAJ Can Med Assoc J"},{"issue":"6","key":"6801_CR47","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/bcp.12885","volume":"81","author":"I Metushi","year":"2016","unstructured":"Metushi I, Uetrecht J, Phillips E. Mechanism of isoniazid-induced hepatotoxicity: then and now. Br J Clin Pharmacol. 2016;81(6):1030\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"6801_CR48","first-page":"359","volume":"132","author":"SK Sharma","year":"2010","unstructured":"Sharma SK. Zidovudine-induced anaemia in HIV\/AIDS. Indian J Med Res. 2010;132:359\u201361.","journal-title":"Indian J Med Res"},{"issue":"7298","key":"6801_CR49","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/bmj.322.7298.1355","volume":"322","author":"DH Rushton","year":"2001","unstructured":"Rushton DH, Dover R, Sainsbury AW, Norris MJ, Gilkes JJH, Ramsay ID. Why should women have lower reference limits for haemoglobin and ferritin concentrations than men? BMJ. 2001;322(7298):1355\u20137.","journal-title":"BMJ"},{"issue":"1","key":"6801_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12981-019-0246-y","volume":"16","author":"B Castelnuovo","year":"2019","unstructured":"Castelnuovo B, Mubiru F, Kalule I, Kiragga A. Reasons for first line ART modification over the years during the ART scale up in Uganda. AIDS Res Ther. 2019;16(1):31.","journal-title":"AIDS Res Ther"},{"issue":"4","key":"6801_CR51","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4103\/ijmy.ijmy_140_18","volume":"7","author":"A Azeez","year":"2018","unstructured":"Azeez A, Ndege J, Mutambayi R. Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis\/HIV coinfected patients with drug-resistant tuberculosis. Int J Mycobacteriol. 2018;7(4):347.","journal-title":"Int J Mycobacteriol"},{"issue":"5","key":"6801_CR52","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/trstmh\/trv025","volume":"109","author":"TA Umanah","year":"2015","unstructured":"Umanah TA, Ncayiyana JR, Nyasulu PS. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa. Trans R Soc Trop Med Hyg. 2015;109(5):340\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6801_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00180\/full","author":"T Prezzemolo","year":"2014","unstructured":"Prezzemolo T, Guggino G, La Manna MP, Di Liberto D, Dieli F, Caccamo N. Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis. Front Immunol. 2014. https:\/\/doi.org\/10.3389\/fimmu.2014.00180\/full.","journal-title":"Front Immunol"},{"key":"6801_CR54","first-page":"45","volume":"11","author":"J Baluku","year":"2020","unstructured":"Baluku J, Musaazi J, Mulwana R, Mugabo A, Bongomin F, Katagira W. Prevalence and predictors of CD4+ T-lymphocytopenia among HIV-negative tuberculosis patients in Uganda. Res Rep Trop Med. 2020;11:45\u201351.","journal-title":"Res Rep Trop Med"}],"updated-by":[{"DOI":"10.1186\/s12879-023-08014-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000}}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06801-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06801-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06801-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T08:03:34Z","timestamp":1674461014000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06801-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,24]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["6801"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06801-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,24]]},"assertion":[{"value":"13 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12879-023-08014-4","URL":"https:\/\/doi.org\/10.1186\/s12879-023-08014-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods used in the study were carried out in accordance with relevant guidelines and regulations. Study approval was provided by Mulago Hospital Research and Ethics Committee (MHREC) (MHREC 1679). The need of informed consent was waived by MHREC since we used retrospective data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1093"}}